Nerve Graft to Restore Erectile Function During Radical Prostatectomy – Commercial and Individual Exchange Medical Policyopen_in_new

UnitedHealthcare deems autologous (e.g., sural) and allogenic nerve grafting techniques (including end‑to‑side somatic‑to‑autonomic grafting, spider‑silk reconstruction, and other cavernous nerve grafts) to restore erectile function during or after radical prostatectomy investigational and not medically necessary, and therefore not covered. No specific patient‑selection criteria, documentation requirements, or frequency limits are provided to support coverage, and reviewers should follow the member’s benefit plan and any applicable federal/state mandates.

"None — autologous (e."

Sign up to see full coverage criteria, indications, and limitations.